Avi Z. Naider is Director at Loxo Oncology, Inc. (LOXO). They have made 7 open-market trades across 1 company since 2014, most recently 2019-02-15.
CIK 0001612217
3 open-market purchases totalling $351K since 2014, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LOXO | 111,843 | $26.2M |
Shares reported on the most recent Form 4, priced at the 2019-02-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LOXO | BUY | 2018-12-13 | 2018-12-17 | $138.92 | $201K | -3.3% | +68.0% | N/A |
| LOXO | SELL | 2018-01-22 | 2018-01-25 | $100.00 | $1.5M | -5.3% | +10.1% | +29.5% |
| LOXO | SELL | 2017-10-16 | 2017-10-18 | $90.00 | $450K | -0.6% | -14.7% | -2.5% |
| LOXO | SELL | 2017-09-18 | 2017-09-20 | $90.00 | $450K | +2.5% | -3.4% | -10.6% |
| LOXO | SELL | 2017-09-13 | 2017-09-15 | $90.00 | $450K | -5.4% | +1.2% | -6.0% |
| LOXO | BUY | 2015-11-17 | 2015-11-19 | $26.50 | $100K | -23.5% | -1.3% | -30.9% |
| LOXO | BUY | 2014-08-06 | 2014-08-06 | $13.00 | $50K | -23.5% | -1.3% | -1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.